Loading...
01/10 16:01
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call revealed mixed signals: revenue growth and share repurchase are positive, but declining EPS, margins, and unclear guidance are concerns. The Q&A highlighted cost pressures and management's evasive responses, further clouding the outlook. The absence of market cap data limits impact assessment, but the overall sentiment is neutral due to offsetting positive and negative factors.
Consolidated Revenue $585,000,000 to $595,000,000 (up 5% year-over-year at the high end) due to growth in healthcare apparel and contact centers, despite a 1% decline in the fourth quarter.
Diluted EPS $0.13 (down from $0.22 year-over-year) due to tough comparisons from the previous year's strong quarter.
Fourth Quarter Revenue Down 1% year-over-year, with positive growth in healthcare apparel and contact centers offset by a decrease in branded products.
Branded Products Revenue Down 5% year-over-year, primarily due to lower sales of branded uniforms compared to a strong prior year quarter.
Healthcare Apparel Revenue Up 8% year-over-year, driven by growth in digital channels and favorable sales timing.
Contact Centers Revenue Up 4% year-over-year, with new customer contributions offsetting declines from existing customers.
Consolidated Gross Margin 37.1% (down 70 basis points year-over-year) due to increased SG&A as a percentage of revenue.
Branded Products Gross Margin 33.9% (down 1 percentage point year-over-year) driven by sourcing mix and lower volume.
Healthcare Apparel Gross Margin 33.7% (down 3 percentage points year-over-year) due to higher sourcing costs related to manufacturing in Haiti.
Contact Centers Gross Margin 54.7% (up more than 2.5 percentage points year-over-year) due to improved sales force and customer contributions.
Consolidated EBITDA $7,300,000 (down from $9,900,000 year-over-year) due to lower revenue and margin pressures.
Branded Products EBITDA $8,900,000 (down from $11,700,000 year-over-year) due to lower revenue and margin.
Healthcare Apparel EBITDA $1,100,000 (down from $1,400,000 year-over-year) due to margin pressures despite revenue growth.
Contact Centers EBITDA Just over $3,000,000 (up from $2,300,000 year-over-year) due to higher revenue and margin.
Interest Expense $1,500,000 (down from $2,100,000 year-over-year) due to lower average debt and interest rates.
Net Income $2,100,000 (down from $3,600,000 year-over-year) reflecting EBITDA trends.
Year-End Cash and Cash Equivalents $19,000,000 (down from $20,000,000 year-over-year) despite share repurchases and a small acquisition.
Outstanding Debt $86,000,000 (down from $93,000,000 year-over-year) indicating improved financial position.
Operating Cash Flow $33,000,000 for the year, supporting a net leverage ratio of 1.7 times trailing twelve months EBITDA, improved from 2 times.
Share Repurchases Approximately $7,000,000 during the year, with an additional $17,500,000 authorized for future repurchases.
New Products: Achieved modest growth in the promotional products channel driven by a combination of both new and existing customers.
Healthcare Apparel: Investing in sales, branding, and marketing to drive brand awareness and grow digital channels.
Contact Centers: Revenue growth potential with a new sales team in place for the first time since launching this business.
Market Expansion: Expanding market share in branded products and healthcare apparel, particularly in digital channels.
Customer Base Growth: Positive contribution from new customers in contact centers, targeting small and medium-sized enterprises.
Operational Efficiencies: Focusing on cost management and maximizing operational efficiencies to enhance customer experience.
Sales Leadership Investment: Investing in sales leadership to expand share of wallet with existing customers and add new customers.
Strategic Investments: Strong financial foundation allows for strategic investments in attractive end markets and share repurchases.
Acquisition Strategy: Completed a small acquisition to add new blue-chip customers and experienced talent.
Macroeconomic Conditions: The company faces challenges due to customer hesitancy stemming from uncertainty around inflation, interest rates, geopolitical conflicts, and the general economic direction.
Supply Chain Risks: Concerns regarding tariffs and their potential impact on supply chains, leading to increased costs and delays for clients.
Cost Management: Higher sourcing costs related to manufacturing in Haiti have pressured margins, particularly in the healthcare apparel segment.
Competitive Pressures: The company is experiencing competitive pressures in the branded products segment, with a need to maintain market share amidst economic uncertainty.
Customer Demand: There is a noted slowdown in decision-making among prospective clients, impacting new deal consummation despite a strong backlog.
Labor Costs: While labor costs have remained stable, there are spot increases in specific job categories that could affect overall expenses.
Economic Uncertainty: Lingering economic uncertainty is expected to continue influencing customer spending and purchasing decisions.
Strategic Investments: The company is committed to making strategic investments in three attractive end markets while also opportunistically repurchasing shares.
Sales Leadership Investment: Investing in sales leadership to expand share of wallet with existing customers and to add new customers.
Healthcare Apparel Growth: Investing in sales, branding, and marketing to enhance brand awareness and grow digital channels.
Contact Center Strategy: Implementing latest technology to enhance customer experience and optimize costs for long-term profitability.
Acquisition Strategy: Engaging in opportunistic acquisitions to add blue-chip customers and experienced talent.
2025 Revenue Guidance: Expected full year revenues in the range of $585 million to $595 million, suggesting year-over-year growth of up to 5%.
2025 EPS Guidance: Expected earnings per diluted share in the range of $0.75 to $0.82, suggesting 12% year-over-year growth at the high end.
2025 Revenue Pattern: Expecting a back-end weighted revenue pattern similar to previous years.
Interest Expense Outlook: Expecting improved interest expense due to lower average debt and favorable interest rates.
Cost Management: Expecting to manage costs effectively, with potential for passing on cost increases to customers.
Share Repurchase Program: During the fourth quarter, approximately 72,000 shares were repurchased for $1,100,000 at an average price of $14.96 per share. An additional $17,500,000 share repurchase plan has been authorized with no expiration.
Remaining Authorization: Approximately $2,600,000 remains under the initial share repurchase authorization.
Total Share Repurchases: More than $7,000,000 of shares were repurchased during the year.
The earnings report shows mixed results: a decline in revenue and margins, but cost savings and a strong Branded Products pipeline. Despite negative trends in the Contact Center and declining EBITDA, optimistic guidance for revenue growth in Q4 and potential acquisitions provide balance. The Q&A highlights challenges in client retention and tariff impacts, but also potential revenue normalization. Without market cap data, the net effect suggests a neutral stock movement, as the positive and negative factors seem to offset each other.
The earnings call reflects strong financial performance with increased net income and decreased net interest expense. Product development shows potential with AI integration, and market strategy is optimistic despite some uncertainties. Management's reiteration of revenue guidance and successful tariff mitigation efforts are positive indicators. Shareholder return plans are not explicitly mentioned, but overall, the sentiment is positive with a focus on growth and cost efficiency.
The earnings call reveals mixed signals: revenue and EPS declined year-over-year, indicating potential challenges. However, the company maintains strong cash flow and plans for share repurchases, which are positive. The Q&A section highlights some uncertainties, particularly around costs and guidance. The acquisition of blue-chip customers offers growth potential, but management's vague responses on key areas like online channels and future margins suggest caution. Overall, the sentiment is neutral, with no strong catalysts for significant stock price movement.
The earnings call revealed mixed signals: revenue growth and share repurchase are positive, but declining EPS, margins, and unclear guidance are concerns. The Q&A highlighted cost pressures and management's evasive responses, further clouding the outlook. The absence of market cap data limits impact assessment, but the overall sentiment is neutral due to offsetting positive and negative factors.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
